BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that the Company’s subsidiary, ...
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel ...
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that the Fourth Intermediate People ...
BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the ...
SAIF Partners Nominees Will Work Proactively to Help Shareholders Realize Full Value of Sinovac, Including Through the Payment of Significant Dividends and Resumption of Trading of Common Shares ...
Wins bid to supply seasonal flu vaccine in Beijing Shares up 20 pct in pre-market trade Aug 28 (Reuters) - China's Sinovac Biotech Ltd said it won a bid to supply its seasonal influenza vaccine, Anflu ...
Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the China National Medical Products Administration (NMPA ...
Sinovac Biotech (SVA +6.7%) is trading higher after saying it's been selected by the Beijing Centers for Disease Control and Prevention as one of four manufacturers to supply a seasonal influenza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results